Buprenorphine
Buprenorphine can reduce withdrawal and cravings while partially activating opioid receptors.
Fentanyl is a powerful synthetic opioid. Pharmaceutical fentanyl has legitimate medical uses for severe pain and anesthesia, but much of the fentanyl-related overdose harm in the United States is connected to illegally made fentanyl found in the unregulated drug supply.
Illegally manufactured fentanyl can appear in powders, counterfeit pills, heroin, cocaine, methamphetamine, and other substances. A person may sometimes be exposed to fentanyl without knowing it is present.
When fentanyl use becomes difficult to control or continues despite serious harm, a person may have opioid use disorder, often shortened to OUD.
Fentanyl-related opioid use disorder is treatable. Treatment may include medications for opioid use disorder, counseling, behavioral healthcare, withdrawal management when needed, mental health care, overdose-prevention planning, and residential or outpatient treatment depending on the person's circumstances.
The right approach should be based on assessment rather than assuming everyone using fentanyl needs the same treatment program.
Fentanyl addiction is generally treated as opioid use disorder.
Evidence-based treatment can include medications such as buprenorphine, methadone, or naltrexone, together with clinical assessment, behavioral healthcare, recovery support, overdose prevention, and continuing care.
Some people may also need withdrawal-management services before or during treatment. Others may be able to begin medication or outpatient care without entering a separate residential detox program.
A person may receive treatment in a residential facility, outpatient clinic, opioid treatment program, primary-care setting, behavioral-health clinic, or another appropriate healthcare environment.
The important point is that treatment should continue beyond the immediate withdrawal phase.
Fentanyl is a laboratory-made opioid.
There are two very different contexts in which the word fentanyl is commonly used.
Pharmaceutical fentanyl is manufactured under regulated conditions and can be used medically for severe pain or during certain medical procedures.
Illegally made fentanyl is produced outside regulated pharmaceutical systems and distributed through the illegal drug supply.
The difference matters.
A fentanyl medication prescribed and administered appropriately in medical care is not the same situation as an unknown amount of illegally manufactured fentanyl appearing in counterfeit pills or other street drugs.
Much of the current public-health concern around fentanyl involves illegally manufactured fentanyl because the amount present in an unregulated product may be unpredictable.
Like other opioids, fentanyl can slow breathing.
During an opioid overdose, breathing may become extremely slow, shallow, or stop completely.
Illegally made fentanyl creates additional danger because people often do not know exactly what is in the substance they are using.
The concentration of fentanyl may vary from one product to another, and fentanyl may also appear in counterfeit pills that resemble legitimate prescription medications.
Someone may therefore believe they are taking one drug while actually being exposed to fentanyl.
Combining opioids with other substances that slow the central nervous system, such as alcohol or benzodiazepines, can further increase the risk of dangerous sedation and overdose.
Overdose risk is not determined only by how much someone normally uses. Changes in tolerance, unpredictable drug contents, use of multiple substances, and underlying health problems can all affect risk.
Fentanyl remains a major overdose-prevention concern in the United States.
According to the data included in the source plan, final CDC mortality data showed 47,735 overdose deaths in 2024 involving synthetic opioids other than methadone, a category that includes fentanyl and fentanyl analogs. The age-adjusted death rate for this category fell compared with 2023, but the number of deaths remained substantial.
The public-health goal is therefore twofold: reduce overdose deaths now while also making effective opioid use disorder treatment easier to access.
No.
Physical dependence means the body has adapted to repeated opioid exposure. If the opioid is stopped or significantly reduced, withdrawal symptoms may occur.
Opioid use disorder involves a broader pattern of opioid use that causes significant impairment, distress, or repeated harmful consequences.
Someone can experience tolerance or physical dependence without automatically meeting criteria for opioid use disorder.
This distinction is especially important when opioids are being used under appropriate medical supervision.
Withdrawal alone does not diagnose addiction. A qualified healthcare professional evaluates the broader pattern of opioid use and how it affects the person's health and life.
A website cannot diagnose opioid use disorder.
However, certain patterns may indicate that a professional assessment would be useful.
An assessment can help determine whether opioid use disorder is present and what level of care may be appropriate.
Treatment should begin by understanding the person's actual circumstances rather than automatically placing everyone into the same type of rehab.
A treatment assessment may look at recent fentanyl or opioid exposure, withdrawal symptoms, overdose history, other substances being used, medications, physical health, mental health, previous treatment experiences, housing, family or social support, and immediate safety concerns.
From there, the treatment plan may include withdrawal management, medication for opioid use disorder, residential treatment, outpatient care, behavioral treatment, mental health services, overdose-prevention planning, or a combination of these services.
The plan can also change over time.
Someone may begin with a more intensive level of care and later move into outpatient treatment. Another person may begin treatment in the community and need more support if risks increase.
Regular opioid exposure can lead to physical dependence.
When opioid levels fall, withdrawal symptoms may begin.
Opioid withdrawal can involve restlessness, anxiety, difficulty sleeping, sweating, muscle aches, nausea, vomiting, diarrhea, stomach discomfort, and strong cravings.
The experience can vary significantly from one person to another.
Other substances, medications, medical conditions, and patterns of opioid use can also affect withdrawal.
Someone considering stopping fentanyl or another opioid should discuss the situation with an appropriate healthcare professional, particularly if other substances are involved, there is a significant medical condition, pregnancy is present, or previous withdrawal has been difficult.
No.
Detox can help someone through the immediate physical process of stopping opioid use.
Depending on the situation, detox may provide medical monitoring, medications, symptom management, hydration, stabilization, and planning for the next phase of treatment.
Detox does not by itself address the full opioid use disorder.
A person may finish withdrawal and still experience cravings, triggers, mental health symptoms, unstable housing, high-risk social environments, or other factors that make returning to opioid use more likely.
For this reason, withdrawal management should generally connect directly into ongoing treatment.
That next stage may involve medication for opioid use disorder, behavioral healthcare, outpatient treatment, residential care, mental health services, peer support, and other recovery resources.
The site's drug detox programs guide explains professional withdrawal-management services in more detail.
Because fentanyl is an opioid, opioid use disorder involving fentanyl can be treated with the FDA-approved medications used for OUD more broadly.
Buprenorphine can reduce withdrawal and cravings while partially activating opioid receptors.
Methadone is a full opioid agonist used in regulated opioid treatment programs and can reduce withdrawal and cravings.
Naltrexone works differently by blocking opioid receptors and requires an appropriate opioid-free period before treatment begins.
The right medication is not simply the “strongest” medication.
A clinician may consider recent opioid use, physical dependence, previous treatment, health conditions, pregnancy, treatment setting, access, and personal preferences.
Medication for opioid use disorder should be understood as treatment in its own right, not simply as a short-term detox aid.
For a broader overview of opioid treatment, readers can continue to the opioid addiction treatment guide.
Buprenorphine is widely used to treat opioid use disorder.
It can reduce opioid withdrawal symptoms and cravings and can be prescribed in a broader range of healthcare settings than methadone for OUD.
Starting buprenorphine should be guided by a qualified clinician.
This can be especially important when fentanyl is involved because recent opioid exposure and the person's withdrawal state can affect how treatment is started.
A health-information website should not provide a do-it-yourself dosing or medication-start schedule. The timing and treatment plan should be individualized.
Methadone is another evidence-based medication used to treat opioid use disorder.
It can reduce withdrawal and cravings and provide more stable opioid-receptor activity.
In the United States, methadone used specifically for OUD is generally dispensed through certified opioid treatment programs.
Current treatment rules allow clinicians more flexibility than older models in deciding how treatment and take-home medication may be managed, although the exact arrangement depends on the patient, program, and applicable rules.
Methadone can be used as ongoing treatment rather than only for a short detoxification period.
Naltrexone works differently from methadone and buprenorphine.
It is an opioid antagonist, meaning it blocks opioid receptors rather than activating them.
For opioid use disorder, extended-release injectable naltrexone is one treatment option.
Because naltrexone can trigger severe withdrawal if started while opioids are still active in the body, treatment generally requires an appropriate opioid-free period first.
A person actively using fentanyl should not try to decide independently when to start naltrexone. That decision should be handled by a qualified healthcare professional.
No.
Counseling and behavioral treatment can be very helpful, but access to evidence-based medication for opioid use disorder should not automatically depend on completing therapy first.
Medication may address important biological parts of opioid use disorder, including withdrawal and cravings.
Behavioral treatment can help with other parts of recovery, such as stress, decision-making, relationships, triggers, routines, trauma, and mental health.
The better way to think about treatment is medication together with individualized behavioral and recovery support when those services are appropriate and available.
Therapy can help address the behavioral, emotional, and practical aspects of opioid use disorder.
Therapy should support the treatment plan rather than being treated as a substitute for medication when medication is clinically appropriate.
No.
Fentanyl exposure alone does not determine what treatment setting a person needs.
Some people benefit from residential or inpatient care because they need more structure, medical monitoring, a safer recovery environment, or more intensive mental health support.
The inpatient drug rehab guide explains structured treatment settings in more detail.
Others may be treated effectively in outpatient settings.
Outpatient treatment can include medication, counseling, psychiatric care, medical follow-up, telehealth, and recovery support while the person continues living outside the treatment facility.
The outpatient drug rehab guide explains community-based treatment levels.
The decision should consider withdrawal risk, overdose history, mental and physical health, other substances, living environment, ability to attend treatment, previous treatment experiences, and overall safety.
The appropriate level of care should be based on the whole situation rather than the word “fentanyl” alone.
Some people seeking fentanyl or opioid treatment also experience depression, anxiety, trauma-related symptoms, bipolar disorder, or other mental health concerns.
These issues should not automatically be treated as separate from addiction care.
Mental health symptoms can affect substance use, treatment participation, safety, sleep, relationships, and recovery.
A comprehensive assessment can help determine whether coordinated treatment is appropriate.
That may involve therapy, psychiatric evaluation, mental health medication, case management, safety planning, and addiction treatment working together.
The dual diagnosis treatment guide provides more information about integrated care.
A fentanyl overdose can dangerously slow or stop breathing.
Try to support breathing, place the person on their side to reduce choking risk, and stay with them until emergency help arrives.
Naloxone can reverse an opioid overdose, including fentanyl overdose.
More than one dose may sometimes be required, but emergency medical services should still be contacted.
Naloxone is an emergency overdose-reversal medication. It is not treatment for opioid use disorder itself.
Overdose prevention should be part of opioid use disorder treatment.
People receiving treatment, family members, household members, and other close contacts may benefit from understanding how to recognize overdose and how naloxone works.
Treatment programs should also discuss reduced tolerance.
After a period of reduced or no opioid use, a person's previous opioid tolerance may be lower.
Returning to an amount that was previously tolerated can therefore become especially dangerous.
Overdose-prevention education should continue throughout treatment rather than only being discussed at the beginning.
Yes.
Illegally manufactured fentanyl can be mixed with other substances or pressed into counterfeit pills.
Someone who believes they are using cocaine, methamphetamine, heroin, or a counterfeit prescription pill may therefore be exposed to fentanyl unexpectedly.
This can also matter during treatment assessment.
A person seeking treatment for another substance may need to discuss possible fentanyl exposure with the treatment team.
Fentanyl test strips may help identify the presence of fentanyl in some drug samples, but they do not make an unregulated product safe.
A negative result cannot guarantee that fentanyl or another dangerous substance is absent, and test strips do not tell someone exactly how much fentanyl is present.
A return to opioid use can be dangerous, but it does not automatically mean treatment should end.
It may indicate that the treatment plan needs to change.
Medication may need to be reviewed.
Treatment intensity may need to increase.
Mental health symptoms, unstable housing, ongoing exposure to high-risk environments, transportation problems, or other barriers may also be affecting progress.
One major safety concern is loss of opioid tolerance.
After a period of abstinence or reduced use, a dose someone previously tolerated may become much more dangerous.
Treatment should therefore include a plan for difficult moments rather than assuming recovery will always be perfectly linear.
Family members and close friends can provide meaningful support without becoming responsible for another person's recovery.
Family members may also participate in family services when appropriate.
Support does not mean trying to become the person's doctor or detox provider.
Family members should not attempt to manage medical withdrawal at home when professional care is needed.
Recovery does not end when detox, residential treatment, or intensive outpatient care ends.
Those services may be only one stage of a longer treatment process.
Continuing care may also involve case management, family services, and other community-based support.
Some people continue medication for months, years, or longer.
The next level of care should be based on the person's progress, safety, recovery environment, ongoing needs, and treatment preferences.
One of the most important things to ask is how the program treats opioid use disorder.
Ask whether the program provides or coordinates buprenorphine, methadone, or naltrexone when appropriate.
Ask how naloxone education and overdose-prevention planning are handled.
Ask what happens when medical care is needed during withdrawal.
Ask how depression, anxiety, trauma, or another mental health condition is addressed.
Ask how medication, counseling, and recovery support continue after discharge.
The answer can reveal a great deal about how the facility approaches opioid treatment.
Many health insurance plans provide benefits for substance use disorder treatment, but actual coverage varies.
Coverage may depend on the treatment provider, network status, level of care, medical-necessity criteria, prior authorization, deductible, copayments, coinsurance, and prescription benefits.
Different parts of treatment may also be billed differently.
Withdrawal management, residential treatment, outpatient counseling, physician visits, mental health care, and medications may each be processed under different parts of an insurance plan.
Readers can use the site's verify insurance for rehab resource and review how much rehab costs for broader cost information.
Yes. Opioid use disorder involving fentanyl is treatable. Treatment can include medications for OUD, behavioral healthcare, overdose-prevention services, mental health care, and different treatment settings based on individual needs.
The FDA-approved medications used to treat opioid use disorder are buprenorphine, methadone, and naltrexone. The appropriate medication depends on the person and should be selected with a qualified healthcare professional.
No. Detox can address withdrawal, but opioid use disorder usually requires continuing treatment beyond withdrawal management.
No. Some people need residential or inpatient care, while others can safely receive treatment in outpatient, primary-care, opioid-treatment-program, or other settings.
Yes. Buprenorphine is used to treat opioid use disorder involving fentanyl. Starting treatment should be managed by a qualified clinician rather than through a self-directed dosing plan.
Methadone is an evidence-based medication used to treat opioid use disorder. When used appropriately in treatment, it can reduce withdrawal and cravings and support stabilization.
Yes. Illegally made fentanyl may appear in heroin, cocaine, methamphetamine, counterfeit pills, and other substances without the person knowing it is present.
No. Test strips may detect fentanyl in some samples, but they do not determine the exact amount and cannot guarantee that an unregulated drug is safe.
Yes. Naloxone can reverse an opioid overdose, including one involving fentanyl, when given in time. Emergency medical services should still be contacted.
Give naloxone if available, call 911, support breathing if possible, place the person on their side, and stay with them until help arrives.
No. Physical dependence can cause withdrawal. Opioid use disorder involves a broader pattern of problematic opioid use and significant impairment or distress.
Treatment may continue through medications for opioid use disorder, outpatient therapy, mental health services, peer support, recovery housing, primary care, or other services depending on individual needs.
You do not need to decide by yourself whether medication treatment, withdrawal management, residential care, outpatient treatment, mental health services, or another option is the right starting point.
Treatment can be explored based on opioid use, withdrawal risk, overdose history, physical and mental health, other substances, living environment, location, and insurance circumstances.
This page provides general educational information about fentanyl, opioid use disorder, withdrawal, medications, treatment settings, overdose prevention, naloxone, and recovery.
It is not medical advice and should not be used to diagnose opioid use disorder, choose a prescription medication, determine a medication dose, or replace individualized medical care.
Medication decisions involving buprenorphine, methadone, naltrexone, or other treatments should be made with an appropriately qualified healthcare professional.
For a mental health, suicide, or substance-use crisis, call or text 988.